i
Advanced molecular detection : AMD: translating genomic data into public health action
-
Mar 16 2023
-
Series: NZEID accomplishments 2022
Details:
-
Corporate Authors:
-
Description:When new variants of SARS-CoV-2 (the virus that causes COVID-19) were first detected in 2020, scientists across the world turned to genomic sequencing to discover how variants might affect COVID-19 and countermeasures—like vaccines and therapeutics—being developed to combat it. The efforts to control the pandemic coupled with the increasing demand for other innovative solutions made possible by sequencing have spurred renewed interest in the role of pathogen genomics in public health.
For the past several years, NCEZID’s innovative and modernizing initiative, the Advanced Molecular Detection (AMD) program, has worked closely with CDC programs and state and local health departments to bring genomic sequencing of pathogens into routine use, identify and implement new genomic technology innovations, and transform infectious disease detection.
AMD has accelerated innovation and stakeholder partnerships in new ways—harnessing the collective efforts of public health and academic expertise to advance the application of genomics to better protect the health of all Americans.
CS328934V
advanced-molecular-detection.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Pages in Document:2 unnumbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: